000 | 01970 a2200565 4500 | ||
---|---|---|---|
005 | 20250516190015.0 | ||
264 | 0 | _c20140325 | |
008 | 201403s 0 0 eng d | ||
022 | _a1550-6606 | ||
024 | 7 |
_a10.4049/jimmunol.1300123 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aBignon, Alexandre | |
245 | 0 | 0 |
_aCCR1 inhibition ameliorates the progression of lupus nephritis in NZB/W mice. _h[electronic resource] |
260 |
_bJournal of immunology (Baltimore, Md. : 1950) _cFeb 2014 |
||
300 |
_a886-96 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAge Factors |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aB-Lymphocytes _ximmunology |
650 | 0 | 4 |
_aChemokine CCL3 _xbiosynthesis |
650 | 0 | 4 |
_aChemokine CCL5 _xbiosynthesis |
650 | 0 | 4 | _aChemotaxis, Leukocyte |
650 | 0 | 4 | _aDisease Progression |
650 | 0 | 4 | _aDrug Evaluation, Preclinical |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aKidney _ximmunology |
650 | 0 | 4 | _aLigands |
650 | 0 | 4 |
_aLupus Nephritis _ximmunology |
650 | 0 | 4 | _aMice |
650 | 0 | 4 | _aMice, Inbred NZB |
650 | 0 | 4 |
_aMyeloid Cells _xdrug effects |
650 | 0 | 4 |
_aNeutrophil Infiltration _xdrug effects |
650 | 0 | 4 |
_aRNA, Messenger _xbiosynthesis |
650 | 0 | 4 | _aRandom Allocation |
650 | 0 | 4 |
_aReceptors, CCR1 _xantagonists & inhibitors |
650 | 0 | 4 |
_aSpleen _ximmunology |
650 | 0 | 4 |
_aSplenomegaly _xetiology |
650 | 0 | 4 |
_aT-Lymphocyte Subsets _xdrug effects |
700 | 1 | _aGaudin, Françoise | |
700 | 1 | _aHémon, Patrice | |
700 | 1 | _aTharinger, Hugo | |
700 | 1 | _aMayol, Katia | |
700 | 1 | _aWalzer, Thierry | |
700 | 1 | _aLoetscher, Pius | |
700 | 1 | _aPeuchmaur, Michel | |
700 | 1 | _aBerrebi, Dominique | |
700 | 1 | _aBalabanian, Karl | |
773 | 0 |
_tJournal of immunology (Baltimore, Md. : 1950) _gvol. 192 _gno. 3 _gp. 886-96 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.4049/jimmunol.1300123 _zAvailable from publisher's website |
999 |
_c23394511 _d23394511 |